Marc Espié
Impact in
- Cancer Research top 0.5%
- Breast Cancer Treatment Studies
- Oncology top 1%
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- Cancer-related Molecular Pathways
Papers in
-
- Breast Cancer Treatment Studies 87
- Oncology 64
- Cancer Treatment and Pharmacology 24
- HER2/EGFR in Cancer Research 18
- Cancer Risks and Factors 8
- Co-authors
- Michel E. Marty (55 shared papers)Sylvie Giacchetti (54 shared papers)David Groheux (33 shared papers)Elif Hindié (28 shared papers)Anne de Roquancourt (38 shared papers)Caroline Cuvier (41 shared papers)Philippe Bertheau (22 shared papers)Laëtitia Vercellino (12 shared papers)
- Journals
- Annals of Oncology (12 papers)European Journal of Cancer (9 papers)British Journal of Cancer (8 papers)Journal of Nuclear Medicine (8 papers)Journal of Clinical Oncology (7 papers)
- Partner nations
- FranceUnited StatesItaly
In The Last Decade
Marc Espié
181 papers receiving 7.7k citations
Marc Espié's Hit Papers
Peers
Comparison fields: 5 of 106
- Cancer Research 2.7k
- Oncology 2.3k
- Radiology, Nuclear Medicine and Imaging 1.8k
- Pathology and Forensic Medicine 610
- Pulmonary and Respiratory Medicine 578
Countries citing papers authored by Marc Espié
This map shows the geographic impact of Marc Espié's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Espié with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Espié more than expected).
Fields of papers citing papers by Marc Espié
This network shows the impact of papers produced by Marc Espié. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Espié. The network helps show where Marc Espié may publish in the future.
Co-authors
The 25 scholars most cited alongside Marc Espié, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 199 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 469 | |
| 2 | Ipatasertib plus paclitaxel versus placebo plus paclitaxel as first-line therapy for metastatic triple-negative breast cancer (LOTUS): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial Hit paper breakdown → | 2017 | 415 |
| 3 | 2010 | 341 | |
| 4 | 1990 | 309 | |
| 5 | 2013 | 266 | |
| 6 | 2004 | 208 | |
| 7 | 2012 | 205 | |
| 8 | 2006 | 169 | |
| 9 | 2013 | 163 | |
| 10 | 2008 | 160 | |
| 11 | 2012 | 146 | |
| 12 | 1996 | 143 | |
| 13 | 2020 | 140 | |
| 14 | 2007 | 139 | |
| 15 | 2002 | 136 | |
| 16 | 2001 | 130 | |
| 17 | 2012 | 129 | |
| 18 | 2015 | 110 | |
| 19 | 1998 | 108 | |
| 20 | 2012 | 106 |
About Marc Espié
Marc Espié is a scholar working on Cancer Research, Oncology, Pathology and Forensic Medicine, Radiology, Nuclear Medicine and Imaging and Pulmonary and Respiratory Medicine, having authored 199 papers that have together received 7.9k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (87 papers), Breast Lesions and Carcinomas (26 papers), Cancer Treatment and Pharmacology (24 papers), Medical Imaging Techniques and Applications (23 papers), HER2/EGFR in Cancer Research (18 papers), MRI in cancer diagnosis (8 papers), Cancer Risks and Factors (8 papers) and BRCA gene mutations in cancer (7 papers). The work is most often cited by research in Cancer Research (2.7k citations), Oncology (2.3k citations), Radiology, Nuclear Medicine and Imaging (1.8k citations), Pathology and Forensic Medicine (610 citations) and Pulmonary and Respiratory Medicine (578 citations). Marc Espié has collaborated with scholars based in France, United States and Italy. Frequent co-authors include Michel E. Marty, Sylvie Giacchetti, David Groheux, Elif Hindié, Anne de Roquancourt, Caroline Cuvier, Philippe Bertheau, Laëtitia Vercellino, Anne‐Sophie Hamy and Jacqueline Lehmann‐Che. Their work appears in journals such as Annals of Oncology, European Journal of Cancer, British Journal of Cancer, Journal of Nuclear Medicine and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.